October 30,2007
Grassley delves further into FDA review of foreign-made pharmaceuticals
WASHINGTON — Sen. Chuck Grassley is following up on his initial inquiry of the Food and Drug Administration regarding its work to ensure the safety of foreign-made pharmaceutical ingredients and medicines with a series of questions about foreign inspection funding, FDA registration of foreign plants, newly emerging exporters of pharmaceuticals, and weaknesses in the foreign inspection process.
The text of the letter he sent today to the FDA Commissioner follows here, along with the text of his August letter.
###
Next Article Previous Article
Recent News
- Wyden, Sanders Demand Answers from Trump Administration Over Mass Layoffs that Threaten the Wellbeing of Children and Families
- Wyden, Sanders Demand Answers from Trump Administration Over Mass Layoffs that Threaten the Wellbeing of Children and Families
- Wyden, Cortez Masto Call for Criminal Investigation into Evidence of Fraud by Promoters Affiliated with IRS Nominee Billy Long
- Wyden Statement on Social Security Using Death Master List to Revoke Social Security Numbers
- Wyden, Whitehouse Lead Colleagues in Demanding Answers on DOGE’s Access to the Sensitive National Child Support Database